The Multi-Purpose Tool of Tumor Immunotherapy: Gene-Engineered T Cells.

Mo, Zeming; Du, Peixin; Wang, Guoping; Wang, Yongsheng

Mo, Zeming; Du, Peixin; Wang, Guoping; Wang, Yongsheng.

Afiliación

Mo Z; Department of Thoracic Oncology, State Key Laboratory of Biotherapy and Cancer center, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan, China 610041.
Du P; Department of Thoracic Oncology, State Key Laboratory of Biotherapy and Cancer center, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan, China 610041.
Wang G; Department of Thoracic Oncology, State Key Laboratory of Biotherapy and Cancer center, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan, China 610041.
Wang Y; Department of Thoracic Oncology, State Key Laboratory of Biotherapy and Cancer center, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan, China 610041.

J Cancer ; 8(9): 1690-1703, 2017.

Article en En | MEDLINE | ID: mdl-28775789

Palabras clave

Adoptive T cell therapy; Gene-engineered T cell; Tumor associated antigen; Tumor immunotherapy; Viral vectors and non-viral vectors.

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Cancer Año: 2017 Tipo del documento: Article Pais de publicación: Australia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google